Birzeit Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Birzeit Pharmaceuticals has a total shareholder equity of $99.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $121.5M and $21.8M respectively. Birzeit Pharmaceuticals's EBIT is $6.1M making its interest coverage ratio 605.6. It has cash and short-term investments of $12.9M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | 605.6x |
| Cash | US$12.93m |
| Equity | US$99.70m |
| Total liabilities | US$21.81m |
| Total assets | US$121.51m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: BPC's short term assets ($66.4M) exceed its short term liabilities ($9.5M).
Long Term Liabilities: BPC's short term assets ($66.4M) exceed its long term liabilities ($12.4M).
Debt to Equity History and Analysis
Debt Level: BPC is debt free.
Reducing Debt: BPC has no debt compared to 5 years ago when its debt to equity ratio was 5.6%.
Debt Coverage: BPC has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: BPC has no debt, therefore coverage of interest payments is not a concern.